Volumen: 5 # Number : 1
Publication Date : Enero - Abril Year: 2001
Authors: Dr. Jose Ceresetto, Jose F. Estepo, Osvaldo D. Manuale, Susana Meschengieser
Abstract: We should offer anticoagulation (INR 2-3) to patients with atrial fibrillation and valvular disease. We should also anticoagulate patients with high risk cardioembolic nonvalvular atrial fibrillation like: 1- Prior stroke, transient ischemic attack or peripheral embolia. 2- Diabetes. 3- Sistolic hypertension > 160 mmHg. 4- Recent heart failure. 5- age > 75 years and female gender. We should not offer anticoagulant therapy to patients with lone atrial fibrilation and also to patients with low cardioembolic risk atrial fibrillation and high risk of bleeding like: 1- Prior gastrointestinal bleeding, 2- Hemorragic diathesis, 3- Poor compliance to anticoagulant treatment. 4- Comorbid severe disease. In this patients we may use aspirin 325 mg daily. Advanced age is not a contradiction to anticoagulation but it could justify more frequent blood test controls.
Key words: atrial fibrilation, anticoagulation
Pages : 15-17
|
